Table 2.
Interval, s |
||||
---|---|---|---|---|
R-R | P-R | QRS | Q-T | |
Working heart | ||||
Start of protocol | 0.422 ± 0.029 | 0.078 ± 0.010 | 0.045 ± 0.002 | 0.180 ± 0.017 |
End of protocol | 0.412 ± 0.005 | 0.078 ± 0.022 | 0.046 ± 0.001 | 0.158 ± 0.024 |
Langendorff | ||||
Start of protocol | 0.403 ± 0.054 | 0.071 ± 0.014 | 0.044 ± 0.012 | 0.177 ± 0.005 |
End of protocol | 0.404 ± 0.056 | 0.066 ± 0.011 | 0.034 ± 0.002 | 0.175 ± 0.025 |
Blebbistatin | ||||
Start of protocol | 0.438 ± 0.113 | 0.072 ± 0.010 | 0.032 ± 0.000 | 0.167 ± 0.017 |
End of protocol | 0.469 ± 0.236 | 0.065 ± 0.025 | 0.031 ± 0.001 | 0.166 ± 0.009 |
In vivo data (Kour et al. 2013) | 0.240–0.359 | 0.040–0.080 | 0.040–0.120 | 0.080–0.160 |
Values are means ± SD; n = 2. ECG parameters (R-R interval, P-R interval, QRS interval, and Q-T interval) for working, Langendorff, and mechanically arrested hearts are compared at the beginning and at the end of pacing protocols. In vivo values are also included for comparison.